The inconsistencies in the published data may partly originate from the paradoxical effects of ADT on tumor size and PSMA expression, reducing tumor mass as a result of prostate cancer cell death while increasing PSMA expression per cell at the same time. The gene discussed is FOLH1; the disease is prostate cancer.